×

Preparation of 19-Nor-vitamin D compounds

  • US 5,856,536 A
  • Filed: 02/07/1997
  • Issued: 01/05/1999
  • Est. Priority Date: 08/07/1992
  • Status: Expired due to Term
First Claim
Patent Images

1. A 20-epi-19-nor-vitamin D compound having the structure:

  • where each of X1 and X2, independently represents hydrogen or a hydroxy-protecting group, and where R is represented by the structure;

    ##STR14## where Z is selected from Y, --OY, --CH2 OY, --C.tbd.CY and --CH═

    CHY, where the double bond may have the cis or trans stereochemical configuration, and where Y is selected from hydrogen, methyl, --CR5 O and a radical of the structure;

    ##STR15## where m and n, independently, represent integers from 0 to 5, where R1 is selected from hydrogen, hydroxy, protected hydroxy, fluoro, trifluoromethyl, and C1-5 -alkyl, which may be straight chain or branched and, optionally, bear a hydroxy or protected-hydroxy substituent, and where each of R2, R3, and R4, independently is selected from hydrogen, fluoro, trifluoromethyl and C1-5 -alkyl, which may be straight-chain or branched, and optionally, bear a hydroxy or protected-hydroxy substituent, and where R1 and R2, taken together, represent an oxo group, or an alkylidene group, ═

    CR2 R3, or the group --(CH2)p --, where p is an integer from 2 to 5, and where R3 and R4, taken together represent an oxo group, or the group --(CH2)q --, where q is an integer from 2 to 5, and where R5 represents hydrogen, hydroxy, protected hydroxy, or C1-5 alkyl.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×